Displays

Display Therapeutics is a biotechnology company based in Nancy, France, that specializes in the discovery and development of targeted therapeutic agents using its proprietary DTX platform. The company leverages advanced phage display technology to identify high-affinity peptides and nanobodies capable of crossing biological barriers, such as the blood-brain barrier, or targeting specific tumor cells. Their business model focuses on developing an internal pipeline of targeted drug delivery candidates while establishing strategic partnerships with pharmaceutical companies to enhance the delivery of various payloads, including small molecules and biologics. By optimizing the pharmacokinetic profiles of therapeutics, Display Therapeutics aims to improve efficacy and reduce systemic toxicity in oncology and central nervous system disorders.